1.Extracellular Matrix Revisited: Roles in Tissue Engineering.
Youhwan KIM ; Hyojin KO ; Ik Keun KWON ; Kwanwoo SHIN
International Neurourology Journal 2016;20(Suppl 1):S23-S29
The extracellular matrix (ECM) is a heterogeneous, connective network composed of fibrous glycoproteins that coordinate in vivo to provide the physical scaffolding, mechanical stability, and biochemical cues necessary for tissue morphogenesis and homeostasis. This review highlights some of the recently raised aspects of the roles of the ECM as related to the fields of biophysics and biomedical engineering. Fundamental aspects of focus include the role of the ECM as a basic cellular structure, for novel spontaneous network formation, as an ideal scaffold in tissue engineering, and its essential contribution to cell sheet technology. As these technologies move from the laboratory to clinical practice, they are bound to shape the vast field of tissue engineering for medical transplantations.
Biomedical Engineering
;
Biophysics
;
Cellular Structures
;
Collagen
;
Cues
;
Elastin
;
Extracellular Matrix*
;
Fibronectins
;
Glycoproteins
;
Homeostasis
;
Morphogenesis
;
Tissue Engineering*
2.Erratum: Author name correction. Extracellular Matrix Revisited: Roles in Tissue Engineering.
Youhwan KIM ; Hyojin KO ; Ik Keun KWON ; Kwanwoo SHIN
International Neurourology Journal 2016;20(2):168-168
In this article, the 3rd author's name was misprinted unintentionally. The name should be corrected from 'Ik Keun Kwon' to 'Il Keun Kwon'.
3.Prenatal Diagnosis of Congenital Lipoid Adrenal Hyperplasia (CLAH) by Molecular Genetic Testing in Korean Siblings.
Hyun Sun KO ; Seungok LEE ; Hyojin CHAE ; Sae Kyung CHOI ; Myungshin KIM ; In Yang PARK ; Byung Kyu SUH ; Jong Chul SHIN
Yonsei Medical Journal 2011;52(6):1035-1038
Congenital lipoid adrenal hyperplasia (CLAH) is caused by mutations to the steroidogenic acute regulatory protein (StAR) gene associated with the inability to synthesize all adrenal and gonadal steroids. Inadequate treatment in an infant with this condition may result in sudden death from an adrenal crisis. We report a case in which CLAH developed in Korean siblings; the second child was prenatally diagnosed because the first child was affected and low maternal serum estriol was detected in a prenatal screening test. To our knowledge, this is the first prenatal diagnosis of the Q258X StAR mutation, which is the only consistent genetic cluster identified to date in Japanese and Korean populations.
46, XY Disorders of Sex Development/*diagnosis/*genetics
;
Adrenal Hyperplasia, Congenital/*diagnosis/*genetics
;
Adult
;
Asian Continental Ancestry Group
;
Female
;
Genetic Testing/*methods
;
Humans
;
Korea
;
Prenatal Diagnosis/*methods
4.Public Awareness of Onychomycosis in Korean: A Survey of 621 Participants
Dongyoung ROH ; Hyojin KIM ; Jae Hui NAM ; Je Ho MUN ; Joonsoo PARK ; Jin PARK ; Yang Won LEE ; Jee Bum LEE ; Ji Hyun LEE ; Jong Soo CHOI ; Hyun Chang KO
Korean Journal of Medical Mycology 2018;23(1):15-23
BACKGROUND:
The prevalence of onychomycosis is increasing due to the recent increase of the elderly population and immunosuppressed individuals. Clinical studies on onychomycosis have been reported several times in Korea. However, the public awareness of onychomycosis has not received considerable attention, and there have been no Korean studies focused on it.
OBJECTIVE:
To evaluate public awareness and experience of onychomycosis in Korean.
METHODS:
A total of 621 participants were given questions developed for this survey. Sociodemographic characteristics, public awareness, general knowledge and experience about onychomycosis, and diagnostic and treatment behavior were surveyed.
RESULTS:
According to this survey, 99.5% of respondents have heard of onychomycosis, 79.4% of respondents experienced onychomycosis suspicious symptoms, and 52.8% of them responded that onychomycosis can be completely cured only by cleansing the hands and feet. The rate of self-diagnosis was 64.1% among the respondents who experienced symptoms. Only 23.9% of the respondents who were diagnosed with onychomycosis visited the hospital for the first time. Of the respondents, 54.6% who were treated at the hospital discontinued their treatments before complete cure mainly because of long treatment period.
CONCLUSION
Participants were well aware of onychomycosis, but the rate of self-diagnosis was high. They generally agreed to the importance of hospital treatment, but the number of patients visiting hospital was low. Moreover, people frequently discontinue their hospital treatment despite insufficient treatment duration. Patient's behaviors need to be changed, and the roles of dermatologists are important in the diagnosis, treatment, and education of the patients.
5.Pro-inflammatory Cytokine Levels and Cancer-related Fatigue in Breast Cancer Survivors: Effects of an Exercise Adherence Program
Sung Hae KIM ; Yoon Kyung SONG ; Jeehee HAN ; Yun Hee KO ; Hyojin LEE ; Min Jae KANG ; Hyunki PARK ; Hyangkyu LEE ; Sue KIM
Journal of Breast Cancer 2020;23(2):205-217
Purpose:
This study aimed to determine the effect of an exercise intervention on subjective cancer-related fatigue (CRF) and pro-inflammatory cytokine levels in breast cancer survivors (BCS).
Methods:
BCS with greater than moderate CRF (≥ 4) were recruited and randomly assigned to experimental or control groups. The experimental group participated in a 12-week exercise adherence program (Better Life after Cancer - Energy, Strength, and Support; BLESS). Interleukin (IL)-6 and tumor necrosis factor-α (TNF-α) levels were determined at 3 time points (M1: baseline, M2: post-intervention, and M4: 6 months after intervention). Subjective fatigue was measured using the Korean version of the revised Piper Fatigue Scale.
Results:
In this analysis of participants with physiological fatigue measures available (19 experimental, 21 control), there were no statistically significant differences in IL-6 (F = 1.157, p = 0.341), TNF-α levels (F = 0.878, p = 0.436), and level of fatigue (F = 2.067, p = 0.118) between the 2 groups at baseline. Fatigue in the experimental group showed statistically significant improvement compared to the control only at M2 (p = 0.022). There was no significant relationship between subjective and physiological fatigue at the 3 measurement points.
Conclusion
The BLESS intervention improved CRF in BCS immediately at post-intervention, and this study presents clinical feasibility for the management of CRF in BCS in the early survivorship phase who are already experiencing fatigue.
6.Erratum: Pro-inflammatory Cytokine Levels and Cancer-related Fatigue in Breast Cancer Survivors: Effects of an Exercise Adherence Program
Sung Hae KIM ; Yoon Kyung SONG ; Jeehee HAN ; Yun Hee KO ; Hyojin LEE ; Min Jae KANG ; Hyunki PARK ; Hyangkyu LEE ; Sue KIM
Journal of Breast Cancer 2020;23(5):574-575
7.Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease:A Phase III Placebo-controlled Trial
Yu Kyung CHO ; Myung-Gyu CHOI ; Hyojin PARK ; Ji Won KIM ; Dong Ho LEE ; Kwang Hyun KO ; Sang Gyun KIM ; Hwoon-Yong JUNG ; Su Jin HONG ; Yong Chan LEE ; Si Hyung LEE
Journal of Neurogastroenterology and Motility 2021;27(2):223-230
Background/Aims:
S-isomer (S) pantoprazole is more bioavailable and less dependent on cytochrome 2C19 than is racemic pantoprazole. We aim to evaluate the efficacy and safety of 10 mg S-pantoprazole for treatment of non-erosive reflux disease (NERD).
Methods:
In this phase 3, double-blind, randomized placebo controlled, multicenter study, 174 NERD patients were randomized to one of both treatment groups: 10 mg S-pantoprazole, or placebo once daily for 4 weeks. Symptoms and safety were assessed. The efficacy endpoints were complete relief of symptoms, > 50% improvement of all reflux symptoms and recurrence.
Results:
Eighty-eight patients were assigned to the S-pantoprazole group (25 males, mean 43.7 years old) and 86 to the placebo group (32 males, mean 43.0 years old), and 163 patients were subjected to full Analysis Set. A higher proportion of patients in the S-pantoprazole group had complete symptom relief (42.0 % [34/81] vs 17.1% [14/82], P < 0.001) and > 50% symptom responses (66.0% vs 50.0%, P = 0.010 for heartburn; 64.2% vs 28.0%, P = 0.010 for acid regurgitation; and 51.9% vs 30.5%, P = 0.03 for epigastric discomfort) compared to the placebo group. The factors associated with poor responsiveness to PPI were older age, female, greater body mass index, and severe baseline symptoms.
Conclusions
Low dose of S-pantoprazole (10 mg) for 4 weeks was more efficacious than placebo in providing reflux symptom relief in patients with NERD, especially acid regurgitation. More doses or longer periods of treatment with S-pantoprazole would be needed to completely eliminate symptoms.
8.Epidemiology and Identification of Organisms Causing Superficial Dermatomycoses at Tertiary Hospitals in Korea: A Prospective Multicenter Study
Sang Jin CHEON ; Ji Hyun LEE ; Yang Won LEE ; Joonsoo PARK ; Moo Kyu SUH ; Hyojin KIM ; Je Ho MUN ; Sung Yul LEE ; Jong Soo CHOI ; Eung Ho CHOI ; Jee Bum LEE ; Jin PARK ; Hee Joon YU ; Hyun Chang KO
Korean Journal of Medical Mycology 2018;23(2):45-53
BACKGROUND:
Superficial dermatomycoses are fungal infections of the skin, hair, or nails and are most commonly caused by dermatophytes. Superficial dermatomycoses are very common diseases in the field of dermatology; however, their prevalence and clinical characteristics vary with geographical areas and populations. Moreover, pathogenic species change constantly over time.
OBJECTIVE:
This multicenter study aimed to investigate the epidemiologic and clinical findings of tinea corporis, tinea faciale, and tinea capitis in Korea during 2016-2017. In addition, we sought to identify the pathogenic organism causing these three different types of fungal infections.
METHODS:
Total 453 patients from the dermatology clinics of 13 tertiary hospitals in Korea were enrolled in this study. Information regarding demographic characteristics, comorbidities, occupation, family history of superficial dermatomycoses, suspected routes of infection, and treatment was collected. Fungal cultures and molecular analyses were performed for patients with tinea corporis, tinea faciale, and tinea capitis.
RESULTS:
Of the 453 patients, 275 were men and 178 were women. With respect to past history, 214 patients (53.4%) had at least one comorbidity. Tinea corporis (27.3%) was the most common form of superficial dermatomycosis, followed by tinea pedis (23.2%) and tinea unguium (16.6%). Overall, the fungal culture positivity was 77.8% (126/162). Trichophyton rubrum was the most common causative organism for tinea corporis (66.7%, 68/80) and tinea faciale (43.8%, 14/23), while Microsporum canis was the most common causative organism for tinea capitis (36.7%, 11/23).
CONCLUSION
Trichophyton rubrum was consistently the most common causative organism of superficial dermatomycoses, except for tinea capitis in Korea.
9.Korean Guideline for the Diagnosis and Treatment of Onychomycosis: Purpose and Process of Algorithm Guideline Development
Jin PARK ; Jae Hui NAM ; Ji Hyun LEE ; Joonsoo PARK ; Je Ho MUN ; Yang Won LEE ; Jong Soo CHOI ; Moo Kyu SUH ; Kwang Ho KIM ; Weon Ju LEE ; Jee Bum LEE ; Hyun Chang KO ; Hyojin KIM ;
Korean Journal of Medical Mycology 2018;23(2):33-44
BACKGROUND:
There have been several therapeutic guidelines for onychomycosis in different countries and advances in its diagnosis and treatment. Optimal treatment decision-making is affected by healthcare systems and cultural backgrounds of countries.
OBJECTIVE:
The executive committee for onychomycosis guideline of the Korean Society for Medical Mycology aims to provide up-to-date practical guidelines for onychomycosis management in Koreans.
METHODS:
The committee thoroughly reviewed relevant literature and previous guidelines. The structured algorithmic guideline was developed by experts' consensus.
RESULTS:
The optimal treatments can be selected alone or in combination based on the nail and patient variables. Three major classes of treatment are available: standard (topical or oral antifungals), additional (nail removal), and alternative treatments (laser). Both topical and oral antifungals alone are appropriate for mild onychomycosis, while oral antifungals are primarily recommended for moderate-to-severe cases if not contraindicated. Combined topical and oral antifungals are recommended to increase the efficacy in moderate-to-severe cases. Additional infected nail removal is also considered for moderate-to-severe onychomycosis, which is unresponsive to standard medical treatment alone. Laser therapy can be an alternative without significant side effects when standard medical treatments cannot be applied regardless of onychomycosis severity. After treatment course completion, periodic therapeutic response monitoring and onychomycosis preventive measures should be rendered to reduce recurrence.
CONCLUSION
The Korean consensus guideline provides evidence-based recommendations to promote good outcomes of onychomycosis. The proposed algorithm is simple and easy to comprehend, allowing clinicians to facilitate optimal treatment decision-making for onychomycosis in clinical practice.
10.Efficacy of S-pantoprazole 10 mg in the Symptom Control of Non-erosive Reflux Disease:A Phase III Placebo-controlled Trial
Yu Kyung CHO ; Myung-Gyu CHOI ; Hyojin PARK ; Ji Won KIM ; Dong Ho LEE ; Kwang Hyun KO ; Sang Gyun KIM ; Hwoon-Yong JUNG ; Su Jin HONG ; Yong Chan LEE ; Si Hyung LEE
Journal of Neurogastroenterology and Motility 2021;27(2):223-230
Background/Aims:
S-isomer (S) pantoprazole is more bioavailable and less dependent on cytochrome 2C19 than is racemic pantoprazole. We aim to evaluate the efficacy and safety of 10 mg S-pantoprazole for treatment of non-erosive reflux disease (NERD).
Methods:
In this phase 3, double-blind, randomized placebo controlled, multicenter study, 174 NERD patients were randomized to one of both treatment groups: 10 mg S-pantoprazole, or placebo once daily for 4 weeks. Symptoms and safety were assessed. The efficacy endpoints were complete relief of symptoms, > 50% improvement of all reflux symptoms and recurrence.
Results:
Eighty-eight patients were assigned to the S-pantoprazole group (25 males, mean 43.7 years old) and 86 to the placebo group (32 males, mean 43.0 years old), and 163 patients were subjected to full Analysis Set. A higher proportion of patients in the S-pantoprazole group had complete symptom relief (42.0 % [34/81] vs 17.1% [14/82], P < 0.001) and > 50% symptom responses (66.0% vs 50.0%, P = 0.010 for heartburn; 64.2% vs 28.0%, P = 0.010 for acid regurgitation; and 51.9% vs 30.5%, P = 0.03 for epigastric discomfort) compared to the placebo group. The factors associated with poor responsiveness to PPI were older age, female, greater body mass index, and severe baseline symptoms.
Conclusions
Low dose of S-pantoprazole (10 mg) for 4 weeks was more efficacious than placebo in providing reflux symptom relief in patients with NERD, especially acid regurgitation. More doses or longer periods of treatment with S-pantoprazole would be needed to completely eliminate symptoms.